Teclistamab is safe and effective in relapse refractory multiple myeloma patients with end stage renal disease: a case series

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

引用 0|浏览0
暂无评分
关键词
refractory multiple myeloma patients,multiple myeloma,renal disease
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要